Tatiana M Garcia-Bates
Overview
Explore the profile of Tatiana M Garcia-Bates including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
380
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Garcia-Bates T, Palma M, Anderko R, Hsu D, Ananworanich J, Korber B, et al.
EBioMedicine
. 2021 Jan;
63:103175.
PMID: 33450518
Background: During early HIV-1 infection, immunodominant T cell responses to highly variable epitopes lead to the establishment of immune escape virus variants. Here we assessed a type 1-polarized monocyte-derived dendritic...
2.
Palma M, Garcia-Bates T, Martins F, Douradinha B
Appl Microbiol Biotechnol
. 2019 May;
103(13):5461.
PMID: 31106390
In the Funding section, the following statement is missing: The MACS cohort study was supported by the NIH, National Institute of Allergy and Infectious Diseases grant U01-AI35041.
3.
Palma M, Garcia-Bates T, Martins F, Douradinha B
Appl Microbiol Biotechnol
. 2019 Apr;
103(13):5183-5192.
PMID: 31020381
Recombinant Saccharomyces cerevisiae strains expressing HIV antigens have shown promising pre-clinical results. Probiotic S. cerevisiae strains naturally induce gut immunity; thus, genetically engineered probiotic strains could be used to stimulate...
4.
Kristoff J, Palma M, Garcia-Bates T, Shen C, Sluis-Cremer N, Gupta P, et al.
EBioMedicine
. 2019 Apr;
43:295-306.
PMID: 30952614
Background: Despite the success of antiretroviral therapy (ART), latent HIV-1 continues to persist in a long-lived population of resting memory CD4 T cells within those who are infected. Finding a...
5.
Garcia-Bates T, Palma M, Shen C, Gambotto A, Macatangay B, Ferris R, et al.
J Virol
. 2018 Dec;
93(5).
PMID: 30541848
Eliciting highly functional CD8 cytotoxic T lymphocyte (CTL) responses against a broad range of epitopes will likely be required for immunotherapeutic control of HIV-1 infection. However, the combination of CTL...
6.
Mazorra Z, Lavastida A, Concha-Benavente F, Valdes A, Srivastava R, Garcia-Bates T, et al.
Front Pharmacol
. 2017 Jul;
8:382.
PMID: 28674498
Survival benefit and long-term duration of clinical response have been seen using the epidermal growth factor receptor (EGFR)-targeted monoclonal antibody (mAb) nimotuzumab. Blocking EGFR signaling may not be the only...
7.
Trivedi S, Srivastava R, Concha-Benavente F, Ferrone S, Garcia-Bates T, Li J, et al.
Clin Cancer Res
. 2016 May;
22(21):5229-5237.
PMID: 27217441
Purpose: EGF receptor (EGFR) is highly overexpressed on several cancers and two targeted anti-EGFR antibodies which differ by isotype are FDA-approved for clinical use. Cetuximab (IgG1 isotype) inhibits downstream signaling...
8.
Garcia-Bates T, Kim E, Concha-Benavente F, Trivedi S, Mailliard R, Gambotto A, et al.
J Immunol
. 2016 Feb;
196(6):2870-8.
PMID: 26851223
The incidence of human papillomavirus (HPV)-related head and neck squamous cell carcinoma has increased in recent decades, though HPV prevention vaccines may reduce this rise in the future. HPV-related cancers...
9.
Nascimento E, Hottz E, Garcia-Bates T, Bozza F, Marques Jr E, Barratt-Boyes S
Crit Rev Immunol
. 2014 Jun;
34(3):227-40.
PMID: 24941075
Dengue is a mosquito-borne disease caused by infection with dengue virus (DENV) that represents a serious and expanding global health threat. Most DENV infections are inapparent or produce mild and...
10.
Garcia-Bates T, Cordeiro M, Nascimento E, Smith A, Soares de Melo K, McBurney S, et al.
J Immunol
. 2012 Dec;
190(1):80-7.
PMID: 23203929
Dengue is a globally expanding disease caused by infection with dengue virus (DENV) that ranges from febrile illness to acute disease with serious complications. Secondary infection predisposes individuals to more...